Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Nov 15;89(22):11041–11045. doi: 10.1073/pnas.89.22.11041

Adoptive transfer of skin-selective autoimmunity induced by Skn alloantigenic disparities.

S H Jackman 1, E A Boyse 1, E H Goldberg 1
PMCID: PMC50479  PMID: 1438311

Abstract

Two unlinked genes of the mouse, Skn-1 and Skn-2, each with alterative alleles, specify alternative cell-surface Skn alloantigens expressed only by epidermal and neural cells. C57BL/6 (B6) and A/J (A) strain mice differ at both Skn loci. Thus lethally irradiated B6 mice restored with (B6 x A)F1 hybrid hematopoietic cells [(B6 x A)/B6 chimeras] reject A strain (Skn-incompatible) skin grafts. Our studies were designed primarily to test the inference that (B6 x A)F1 lymphoid cells, after differentiating in B6 recipients, which lack the Skn alloantigens of A strain mice, may make an Skn-related, skin-selective autoimmune response when returned to their native (B6 x A)F1 habitat. Severe cutaneous lesions did, indeed, ensue after spleen cells of (B6 x A)/B6 chimeras were transferred to (B6 x A)F1 recipients, provided that three conditions were met--namely, (i) priming of the (B6 x A)/B6 chimeric donor by grafting and rejection of Skn-incompatible A strain skin grafts, (ii) stimulation of the recipient's skin as from shaving, at which sites the lesions were mainly located, and (iii) pretreatment of the (B6 x A)F1 recipients with cyclophosphamide or sublethal irradiation. Spleen cells of control female chimeras primed by grafting and rejection of H-Y (Skn-compatible) B6 male skin failed to incite the Skn-typical cutaneous lesions in (B6 x A)F1 recipients, indicating that these lesions were Skn-specific and not a nonspecific consequence of incompatible skin grafting per se. Normally compatible A strain skin grafts, but not Skn-compatible B6 skin grafts, were rejected by cyclophosphamide-treated (B6 x A)F1 recipients of (B6 x A)/B6 spleen cells from Skn-primed chimera donors. Treatment of primed chimeras' spleen cells with antiserum to H-2a (A strain) specifically abolished their capacity to adoptively incite the Skn-related autoimmune syndrome, confirming that the immune cells responsible are of (B6 x A)F1 origin and are not residual B6 derivatives. These findings add weight to the status of Skn systems as agents of tissue-selective histoincompatibility and, perhaps, of clinical disorders with a known or suspected autoimmune basis affecting the skin.

Full text

PDF
11041

Images in this article

11043Image
on p.11043
11043Image
on p.11043

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asarnow D. M., Kuziel W. A., Bonyhadi M., Tigelaar R. E., Tucker P. W., Allison J. P. Limited diversity of gamma delta antigen receptor genes of Thy-1+ dendritic epidermal cells. Cell. 1988 Dec 2;55(5):837–847. doi: 10.1016/0092-8674(88)90139-0. [DOI] [PubMed] [Google Scholar]
  2. Awwad M., North R. J. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity. J Exp Med. 1988 Dec 1;168(6):2193–2206. doi: 10.1084/jem.168.6.2193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boitard C., Yasunami R., Dardenne M., Bach J. F. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med. 1989 May 1;169(5):1669–1680. doi: 10.1084/jem.169.5.1669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boyse E. A., Lance E. M., Carswell E. A., Cooper S., Old L. J. Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure. Nature. 1970 Aug 29;227(5261):901–903. doi: 10.1038/227901a0. [DOI] [PubMed] [Google Scholar]
  5. Boyse E. A., Old L. J. Loss of skin allograft tolerance by chimeras. Transplantation. 1968 Jul;6(4):619–619. doi: 10.1097/00007890-196807000-00015. [DOI] [PubMed] [Google Scholar]
  6. Bryson J. S., Caywood B. E., Kaplan A. M. Relationship of cyclosporine A-mediated inhibition of clonal deletion and development of syngeneic graft-versus-host disease. J Immunol. 1991 Jul 15;147(2):391–397. [PubMed] [Google Scholar]
  7. Bryson J. S., Jennings C. D., Caywood B. E., Kaplan A. M. Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 mice. Transplantation. 1989 Dec;48(6):1042–1047. doi: 10.1097/00007890-198912000-00030. [DOI] [PubMed] [Google Scholar]
  8. Caspi R. R., Roberge F. G., Nussenblatt R. B. Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science. 1987 Aug 28;237(4818):1029–1032. doi: 10.1126/science.2956685. [DOI] [PubMed] [Google Scholar]
  9. Ferrara J., Guillen F. J., Sleckman B., Burakoff S. J., Murphy G. F. Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease. J Invest Dermatol. 1986 Apr;86(4):371–375. doi: 10.1111/1523-1747.ep12285612. [DOI] [PubMed] [Google Scholar]
  10. Fischer A. C., Beschorner W. E., Hess A. D. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease. J Exp Med. 1989 Mar 1;169(3):1031–1041. doi: 10.1084/jem.169.3.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fischer A. C., Laulis M. K., Horwitz L., Beschorner W. E., Hess A. Host resistance to cyclosporine induced syngeneic graft-versus-host disease. Requirement for two distinct lymphocyte subsets. J Immunol. 1989 Aug 1;143(3):827–832. [PubMed] [Google Scholar]
  12. Fischer A. C., Laulis M. K., Horwitz L., Hess A. D. Effect of cyclosporine on T lymphocyte development. Relationship to syngeneic graft-versus-host disease. Transplantation. 1991 Jan;51(1):252–259. doi: 10.1097/00007890-199101000-00042. [DOI] [PubMed] [Google Scholar]
  13. Glazier A., Tutschka P. J., Farmer E. R., Santos G. W. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med. 1983 Jul 1;158(1):1–8. doi: 10.1084/jem.158.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goldberg E. H., Goble R., Jackman S. H. Monoclonal antibodies defining the skin-selective alloantigens, Skn. Immunogenetics. 1990;31(5-6):393–395. doi: 10.1007/BF02115017. [DOI] [PubMed] [Google Scholar]
  15. Havran W. L., Chien Y. H., Allison J. P. Recognition of self antigens by skin-derived T cells with invariant gamma delta antigen receptors. Science. 1991 Jun 7;252(5011):1430–1432. doi: 10.1126/science.1828619. [DOI] [PubMed] [Google Scholar]
  16. Hess A. D., Fischer A. C., Beschorner W. E. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. Role of CD4+ and CD8+ T lymphocyte subsets. J Immunol. 1990 Jul 15;145(2):526–533. [PubMed] [Google Scholar]
  17. Hess A. D., Fischer A. C. Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease. Transplantation. 1989 Dec;48(6):895–900. doi: 10.1097/00007890-198912000-00001. [DOI] [PubMed] [Google Scholar]
  18. Hess A. D., Horwitz L., Beschorner W. E., Santos G. W. Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity. J Exp Med. 1985 Apr 1;161(4):718–730. doi: 10.1084/jem.161.4.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hill J. O., Awwad M., North R. J. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania. J Exp Med. 1989 May 1;169(5):1819–1827. doi: 10.1084/jem.169.5.1819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hood A. F., Vogelsang G. B., Black L. P., Farmer E. R., Santos G. W. Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. Arch Dermatol. 1987 Jun;123(6):745–750. doi: 10.1001/archderm.123.6.745. [DOI] [PubMed] [Google Scholar]
  21. Jackman S. H., De Pirro E. S., Goldberg E. H. Immunohistochemical identification of Skn antigens in mouse epidermis. J Invest Dermatol. 1989 Jul;93(1):46–49. doi: 10.1111/1523-1747.ep12277343. [DOI] [PubMed] [Google Scholar]
  22. Jackman S. H., Goldberg E. H. Demonstration of Skn antigens on mouse epidermal cells by immunofluorescence and flow cytometry. J Invest Dermatol. 1987 May;88(5):574–576. doi: 10.1111/1523-1747.ep12470180. [DOI] [PubMed] [Google Scholar]
  23. Jones R. J., Vogelsang G. B., Hess A. D., Farmer E. R., Mann R. B., Geller R. B., Piantadosi S., Santos G. W. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet. 1989 Apr 8;1(8641):754–757. doi: 10.1016/s0140-6736(89)92575-0. [DOI] [PubMed] [Google Scholar]
  24. Lampert I. A., Janossy G., Suitters A. J., Bofill M., Palmer S., Gordon-Smith E., Prentice H. G., Thomas J. A. Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol. 1982 Oct;50(1):123–131. [PMC free article] [PubMed] [Google Scholar]
  25. North R. J., Awwad M. Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma. Immunology. 1990 Sep;71(1):90–95. [PMC free article] [PubMed] [Google Scholar]
  26. North R. J., Bursuker I. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells. J Exp Med. 1984 May 1;159(5):1295–1311. doi: 10.1084/jem.159.5.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. North R. J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med. 1982 Apr 1;155(4):1063–1074. doi: 10.1084/jem.155.4.1063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Scheid M., Boyse E. A., Carswell E. A., Old L. J. Serologically demonstrable alloantigens of mouse epidermal cells. J Exp Med. 1972 Apr 1;135(4):938–955. doi: 10.1084/jem.135.4.938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Shiohara T., Moriya N., Gotoh C., Hayakawa J., Nagashima M., Saizawa K., Ishikawa H. Loss of epidermal integrity by T cell-mediated attack induces long-term local resistance to subsequent attack. I. Induction of resistance correlates with increases in Thy-1+ epidermal cell numbers. J Exp Med. 1990 Apr 1;171(4):1027–1041. doi: 10.1084/jem.171.4.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Slavin R. E., Santos G. W. The graft versus host reaction in man after bone marrow transplantation: pathology, pathogenesis, clinical features, and implication. Clin Immunol Immunopathol. 1973 Jul;1(4):472–498. doi: 10.1016/0090-1229(73)90005-6. [DOI] [PubMed] [Google Scholar]
  31. Sorokin R., Kimura H., Schroder K., Wilson D. H., Wilson D. B. Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats. J Exp Med. 1986 Nov 1;164(5):1615–1625. doi: 10.1084/jem.164.5.1615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tyler J. D., Galli S. J., Snider M. E., Dvorak A. M., Steinmuller D. Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo. J Exp Med. 1984 Jan 1;159(1):234–243. doi: 10.1084/jem.159.1.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wicker L. S., Miller B. J., Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes. 1986 Aug;35(8):855–860. doi: 10.2337/diab.35.8.855. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES